AHCO icon

AdaptHealth

8.57 USD
+0.19
2.27%
At close May 9, 4:00 PM EDT
After hours
8.90
+0.33
3.85%
1 day
2.27%
5 days
-2.61%
1 month
-12.55%
3 months
-6.44%
6 months
-17.99%
Year to date
-11.65%
1 year
-6.75%
5 years
-46.67%
10 years
-11.65%
 

About: AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Employees: 10,500

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

42% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 59

24% more call options, than puts

Call options by funds: $79.5M | Put options by funds: $63.9M

5.45% more ownership

Funds ownership: 91.92% [Q3] → 97.37% (+5.45%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

8% less funds holding

Funds holding: 216 [Q3] → 199 (-17) [Q4]

10% less capital invested

Capital invested by funds: $1.39B [Q3] → $1.25B (-$141M) [Q4]

48% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 31

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$11
28%
upside
Avg. target
$13.60
59%
upside
High target
$16
87%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
RBC Capital
Ben Hendrix
39% 1-year accuracy
28 / 72 met price target
52%upside
$13
Outperform
Maintained
8 May 2025
Baird
Eric Coldwell
52% 1-year accuracy
15 / 29 met price target
87%upside
$16
Outperform
Maintained
27 Feb 2025
Canaccord Genuity
Richard Close
35% 1-year accuracy
8 / 23 met price target
63%upside
$14
Buy
Maintained
26 Feb 2025
Truist Securities
David Macdonald
60% 1-year accuracy
59 / 98 met price target
63%upside
$14
Buy
Maintained
26 Feb 2025
UBS
Whit Mayo
19% 1-year accuracy
3 / 16 met price target
28%upside
$11
Buy
Maintained
13 Feb 2025

Financial journalist opinion

Based on 6 articles about AHCO published over the past 30 days

Neutral
Seeking Alpha
5 days ago
AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript
AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Suzanne Foster - CEO Jason Clemens - CFO Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Eric Coldwell - Baird Kevin Caliendo - UBS Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Whit Mayo - Leerink Partners John Pinney - Canaccord Genuity Operator Good day, everyone, and welcome to today's AdaptHealth First Quarter 2025 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
5 days ago
AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.
AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates
Neutral
Business Wire
5 days ago
AdaptHealth Corp. Announces First Quarter 2025 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of.
AdaptHealth Corp. Announces First Quarter 2025 Results
Positive
Zacks Investment Research
1 week ago
AdaptHealth (AHCO) Upgraded to Buy: Here's What You Should Know
AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AdaptHealth (AHCO) Upgraded to Buy: Here's What You Should Know
Neutral
Zacks Investment Research
1 week ago
AHCO or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
AHCO or SYK: Which Is the Better Value Stock Right Now?
Neutral
Business Wire
2 weeks ago
AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts an.
AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call
Neutral
Seeking Alpha
1 month ago
Comprehensive Q1 Review Of My Stock Picks + Ratings Updates
Although there is one day left in Q1, I'm pleased to present a detailed review of my Q1 stock picks, along with updated commentary and ratings. Today's report begins with an unconventional review of Apple, which I plan to drop coverage on. This report contains new coverage of 38 stocks that I've previously written about here at Seeking Alpha.
Comprehensive Q1 Review Of My Stock Picks + Ratings Updates
Neutral
Business Wire
2 months ago
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Jefferies Value-Based Healthcare Summit, being held in Miami, on Monday, March 10, 2025, including a fireside chat at 3:45pm ET. The Leerink Part.
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
Positive
Seeking Alpha
2 months ago
My Sleep Apnea Has Led Me To Profits With AdaptHealth
AdaptHealth Corp specializes in sleep therapy equipment and respiratory health. These two focus segments also command the best margins for the company. Q4 2024 results exceeded expectations, driving a 30% stock surge; the company reported a record 12.3% operating income margin.
My Sleep Apnea Has Led Me To Profits With AdaptHealth
Neutral
Zacks Investment Research
2 months ago
AHCO vs. ABT: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
AHCO vs. ABT: Which Stock Is the Better Value Option?
Charts implemented using Lightweight Charts™